Arcoma

Arcoma Earnings Yield

The Earnings Yield of Arcoma (ARCOMA.ST) as of Oct 24, 2026 is 4.63 %. In the previous year, Earnings Yield was 10.28 % — a change of -55.00% (lower).

Earnings Yield

4.63 %

YoY

-55.00%

Last updated:

Earnings Yield of Arcoma is 2025 4.63 % . Earnings Yield of Arcoma was 2024 10.28 % . It decreases by -55.00% lower compared to the previous year.

The Arcoma Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
-1.46 SEK
Jan 1, 2019
6.08 SEK
Jan 1, 2020
1.26 SEK
Jan 1, 2021
-6.87 SEK
Jan 1, 2022
1.75 SEK
Jan 1, 2023
2.36 SEK
Jan 1, 2024
10.28 SEK
Jan 1, 2025
4.63 SEK
The Arcoma Earnings Yield history
YEAREarnings YieldYoY
4.63 %-55.00%
10.28 %+336.00%
2.36 %+34.81%
1.75 %-125.45%
-6.87 %-647.47%
1.26 %-79.35%
6.08 %-516.77%
-1.46 %-83.85%
-9.03 %-15.68%
-10.71 %+80.59%
-5.93 %-805.58%
0.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Earnings Yield of Arcoma is 4.63 % in 2025.

Earnings Yield of Arcoma changed from 10.28 % to 4.63 %, representing a -55.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Arcoma since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Arcoma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Arcoma

All Key Metrics — Arcoma